Quest Diagnostics Inc (DGX) · Oct 22, 2026 · Cybersecurity
Patient-record access — Unauthorized party accessed certain patient records
Quest Diagnostics disclosed a cybersecurity incident involving its Quanum ordering platform and patient-record access, though lab operations remain unaffected.
Quest is a scaled clinical-laboratory business increasingly supported by digital infrastructure. Its Quanum platform helps healthcare providers order tests and access results, while the company’s broader growth strategy combines advanced diagnostics with acquisitions.
The filing adds a real data-security problem, not an operating shutdown. Quest said it learned of unauthorized access to Quanum LSM, the system used by some clients to place orders and view results. 〔0〕 The company believes certain patient records were accessed, but the scope is still under investigation. 〔1〕
The immediate business impact appears contained, but the uncertainty is material. Quest says the incident has not materially disrupted operations or its ability to serve patients. 〔2〕 That preserves the core laboratory story for now, but the unresolved scope leaves open the possibility of patient notifications, regulatory scrutiny, litigation, and remediation work.
Bottom line: This is a new negative development centered on patient-data exposure rather than laboratory disruption. It complicates Quest’s technology and privacy-risk profile, while the filing gives no evidence yet of a material hit to ongoing operations.
Investigation findings and any required patient notifications
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!